WallStreetZenWallStreetZen

NASDAQ: ABUS
Arbutus Biopharma Corp Stock Ownership - Who owns Arbutus Biopharma?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Arbutus Biopharma Corp insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Roivant Sciences LtdDirector2026-10-018,967,383$5.00
$44.84MSell
Robert A. BeardsleyDirector2026-10-0117,948$5.00
$89.74kSell
Lindsay AndroskiCEO;Pres2026-10-0124,655$5.00
$123.28kSell
Tuan NguyenCFO2026-10-0148,081$5.00
$240.41kSell
Roger SawhneyDirector2026-10-0117,142$5.00
$85.71kSell
Robert A. BeardsleyDirector2026-09-1899,057$5.07
$502.22kSell
Lindsay AndroskiCEO;Pres2026-09-18116,408$3.20
$372.51kBuy
Tuan NguyenCFO2026-09-1827,475$4.39
$120.62kBuy
Tuan NguyenCFO2026-09-18206,637$5.07
$1.05MSell
Roger SawhneyDirector2026-09-1852,533$3.34
$175.46kBuy

1 of 2

ABUS insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ABUS insiders and whales buy or sell their stock.

ABUS Shareholders

What type of owners hold Arbutus Biopharma Corp stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Matthew Gline19.64%38,847,462$174.04MInsider
Dexxon Holdings Ltd16.19%32,027,080$143.48MInsider
Roivant Sciences Ltd15.10%29,880,079$133.86MInsider
Vivek Ramaswamy8.12%16,068,455$71.99MInsider
Viking Global Performance LLC8.09%16,013,540$71.74MInsider
Patrick MacHado8.09%16,013,540$71.74MInsider
Svf Investments Uk Ltd8.09%16,013,540$71.74MInsider
Rose Sharon Shabet8.09%16,013,540$71.74MInsider
Qvt Associates GP LLC8.09%16,013,540$71.74MInsider
Dexcel Pharma Technologies Ltd8.09%16,013,540$71.74MInsider

1 of 3

ABUS vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ABUS0.05%99.95%Net SellingNet Selling
SLBT0.00%60.21%Net BuyingNet Buying
AVBP0.09%20.18%Net Selling
GLUE0.08%99.92%Net SellingNet Selling
ODTX0.07%25.83%Net Buying
View Top Biotech Stocks

Arbutus Biopharma Stock Ownership FAQ

Who owns Arbutus Biopharma?

Arbutus Biopharma (NASDAQ: ABUS) is owned by 0.07% institutional shareholders, 136.13% Arbutus Biopharma insiders, and 0.00% retail investors. Matthew Gline is the largest individual Arbutus Biopharma shareholder, owning 38.85M shares representing 19.64% of the company. Matthew Gline's Arbutus Biopharma shares are currently valued at $166.66M.

If you're new to stock investing, here's how to buy Arbutus Biopharma stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.